You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中廣核技(000881.SZ):擬設中廣核醫療健康集團、註冊資本10億元人民幣
格隆匯 02-15 17:58

格隆匯2月15日丨中廣核技(000881.SZ)公佈,為踐行公司“A+”發展戰略,統籌管理核醫療領域的產業與項目,更好地推動核醫療業務高質量發展,公司擬投資設立全資子公司中廣核醫療健康集團有限公司(暫定,以工商部門登記備案名稱為準),註冊資本10億元人民幣,首期以全資子公司中廣核醫療科技(綿陽)有限公司(“醫療科技公司”) 100%股權和中廣核同位素科技(綿陽)有限公司(“同位素公司”)100%股權按評估值(具體以評估備案價值為準)作價注入。

新設子公司將作為公司醫療健康板塊的平台公司,代表公司對核醫療業務進行統籌管理,負責整體業務板塊的戰略規劃、經營統籌、市場推廣、新業務孵化、監督管理與集約化服務。

擬設全資子公司經營範圍:醫用放射性同位素研發、生產、銷售;放射性藥品研發、生產、銷售;體內放射性藥品、體外放射性診斷試劑、靶向藥物技術開發、諮詢、交流、轉讓、推廣、服務;銷售Ⅰ、Ⅱ、Ⅲ、Ⅳ、Ⅴ類放射源;研發、生產、銷售Ⅰ、Ⅱ、Ⅲ類射線裝置;銷售非密封放射性物質;研發、生產、銷售一、二、三類醫療器械、計算機軟件系統;核技術開發、技術諮詢、技術轉讓、技術服務;放射性物品道路運輸;藥品生產、批發、零售;藥品進出口;藥品委託研發、藥品委託生產;電子專用設備製造;電子元器件零售;先進電力電子裝置銷售;電子專用材料銷售;電氣設備銷售;電氣機械設備銷售;投資管理、投資諮詢;技術進出口、貿易進出口、代理進出口;商業房屋租賃服務;信息諮詢服務;工程管理服務。(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以相關部門批准文件或許可證件為準)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account